Using magnetic stimulation and pelvic exercises to treat urinary incontinence after prostate surgery
Official title: Efficacy of Extracorporeal Magnetic Stimulation, Pelvic Floor Muscle Exercise, and Combination of Both in Management of Post Radical Prostatectomy Urinary Incontinence: A Randomized Controlled Trial
Run by Hamad General Hospital · NCT05680168 · Data updated 2026-11-12
This study is testing whether magnetic stimulation, pelvic exercises, or a mix of both can help men with urinary incontinence after prostate surgery feel better.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 80 Years |
| Sex | Men only |
| Enrollment | 60 (estimated) |
| Sponsor | Hamad General Hospital Government |
| Locations | 1 site (Doha) |
| Status | Recruiting |
| Started | January 1, 2023 |
| Main results expected | February 1, 2029 |
| Study ends | December 31, 2029 |
| Registry record updated | January 13, 2023 |
| Trial ID | NCT05680168 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adult males aged 18 and above with localized low to intermediate risk prostate cancer undergoing radical prostatectomy.
✕Probably not a fit
Patients with high-risk prostate cancer, those who had prior treatments like chemotherapy or radiotherapy, or those with pre-existing urinary issues will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study evaluates the effectiveness of extracorporeal magnetic stimulation, pelvic floor muscle exercises, and a combination of both in managing urinary incontinence following radical prostatectomy. Male patients aged 18 and older with localized prostate cancer will be randomized into three groups to receive different treatment modalities. The study aims to determine which approach is most effective in alleviating urinary incontinence symptoms over a period of seven years. Participants will be recruited from the urology department at Hamad General Hospital in Doha.
Why it matters
Potential benefit: If successful, this study could provide a more effective treatment option for men suffering from urinary incontinence after prostate surgery.
How similar studies have gone: Other studies have shown promising results with similar approaches, but this specific combination of treatments is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * The study population will include all adult male patients 18 years of age and above, with localized prostate cancer of low or intermediate risk disease who chose definitive treatment with radical prostatectomy either through open radical retropubic prostatectomy (RRP) or through robotic assissted laparoscopic radical prostatectomy (RALP) as first line for treatment and had the surgery under Hamad General Hospital urology department care. Exclusion Criteria: * Patients with high risk , locally advanced or metastatic prostate cancer at time of diagnosis * Patients with low to intermediate risk prostate cancer who received chemo or radiotherapy then had salvage surgery * Patients with urinary incontinence or diagnosed overactive bladder before radical prostatectomy. * Patients with complicated surgery resulting in anastomotic leak, prolonged catheterisation more than 3 weeks, reinsertion of catheter due to retention of urine. * Patients who refuse to participate in the clinical trial.
Where it's running
-
Ambulatory Care Center
Doha, Qatar Recruiting
Study contacts
- Study coordinator: Ahmed Albakr
- Email: aalbakr3@hamad.qa
- Phone: 33757500
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.